Ascent Group, LLC Astrazeneca PLC Transaction History
Ascent Group, LLC
- $2.65 Billion
- Q3 2025
A detailed history of Ascent Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ascent Group, LLC holds 16,515 shares of AZN stock, worth $1.48 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
16,515
Previous 16,065
2.8%
Holding current value
$1.48 Million
Previous $1.12 Million
12.92%
% of portfolio
0.05%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...